advertisement

Topcon

Wakakura M 2

Showing records 1 to 2 | Display all abstracts from Wakakura M

50306 Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
Inoue K; Okayama R; Higa R; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 607-612
50528 Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
Inoue K; Fujimoto T; Higa R; Moriyama R; Kohmoto H; Nagumo H; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 771-775

Issue 14-2

Change Issue


advertisement

Oculus